Enlonstobart, a recombinant, fully humanised immunoglobulin G4 monoclonal antibody targeted against programmed cell death protein 1 (PD-1),…
Olverembatinib is a small-molecule, oral BCR-ABL1 TKI that works by inhibiting the BCR-ABL1 kinase at the…
Chidamide (also named Tucidinostat) is a histone deacetylase (HDAC) inhibitor that is used to treat various…
About Pirtobrutinib Pirtobrutinib is an inhibits B cell lymphocyte proliferation and survival by binding and inhibiting Bruton's tyrosine…
Golidocitinib (DZD4205) is currently the first and only Janus kinase 1 (JAK1) selective inhibitor being evaluated…
Zuberitamab is an innovative anti-CD20 monoclonal antibody injection. Zuberitamab is a biosimilar of rituximab, a monoclonal…
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab sold under the brand name…
Linperlisib, a next-generation PI3Kδ-selective oral inhibitor, received marketing approval in China in 2022 for treatment of…
Orelabrutinib is a novel, highly selective, irreversible BTK inhibitor with high target selectivity and safety. Orelabrutinib sold…
Cadonilimab is a bispecific antibody that targets the PD-1 and CTLA-4 receptors on tumor cells to…
Zimberelimab is an anti-programmed cell death protein-1 (PD-1) monoclonal antibody being developed by Gloria Biosciences, Arcus…
Gilteritinib is a small molecule part of the FLT3 tyrosine kinase inhibitors that presented a greater…
Brand name: Ventop. Generic name: Venetoclax [Indications] Venetoclax is a bcl-2 inhibitor for the treatment of…
About Enasidenib Enasidenib is a medication used to treat relapsed or refractory acute myeloid leukemia (AML) in people with…
About Fulzerasib Fulzerasib is a novel, orally active, potent KRAS G12C inhibitor designed to effectively target the…
About Ensartinib Ensartinib is a novel, aminopyridazine-based small molecule that potently inhibits ALK. Ensartinib is 10-fold…
Copyright © 2021-2022 LienTeh.net All rights reserved.
